Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders

BACKGROUND: The gonadotrophin-releasing hormone (GnRH) antagonist protocol has some advantages, such as a simple method, short medication duration, and low incidence of ovarian hyperstimulation syndrome, but whether the GnRH antagonist protocol is suitable for normal ovarian responders has been cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Min, Zheng, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112052/
https://www.ncbi.nlm.nih.gov/pubmed/33975553
http://dx.doi.org/10.1186/s12884-021-03849-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112052/
https://www.ncbi.nlm.nih.gov/pubmed/33975553
http://dx.doi.org/10.1186/s12884-021-03849-8

Ejemplares similares